Bromocriptine lowers blood pressure in animals and in man. Results obtained in
experiments performed in the dog and cat suggest three possible mechanisms of action: a) …

Dopamine action appears to play a role in changes that are seen in obesity, metabolic
syndrome and type 2 diabetes mellitus. Bromocriptine-QR (Quick Release), a dopamine …

Aim: The objective of the present study was to assess the efficacy and safety of
bromocriptine treatment for patients with antipsychotic‐drug‐induced hyperprolactinemia in …

A new MS/MS assay for the quantitative determination of bromocriptine in body fluids is
presented. The selective reagent gas in combination with the registration of selected …

Dopamine agonists are the treatment of choice for the majority of patients with
hyperprolactinaemic disorders. Although characterised by a relatively high incidence of …

Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of
Parkinson's disease, postpartum ablaction, prolactionmas, acromegaly, and amenorrhea …

Bromocriptine is a dopamine agonist that induces postural hypotension and can be used as
an antihypertensive. The drug inhibits release of norepinephrine (NE) from an isolated artery …

Introduction Patients with hyperprolactinemia who require medical therapy are typically
treated with dopamine agonists (DAs). In most cases, DAs normalize prolactin levels, control …

The influence of food on release of drug from a modified release capsule of bromocriptine 5
mg (Parlodel SRO) and a conventional formulation of bromocriptine 5 mg has been studied …

1. Plasma bromocriptine levels following separate oral doses of bromocriptine 12.5, 25, 50
and 100 mg have been determined in ten subjects with parkinsonism. 2. There was …